Search
Your search found total of 228 results
NIH Will Consider Your Career Stage If
You submit an R01 grant application
You are an Early Stage Investigator (ESI)
A New Investigator is someone who has not previously received substantial independent funding from NIH. Having received an award for training (such as a fellowship or K award)…
Dr. Gloria Su received her Ph.D. in immunology from the University of Chicago. Her post-doctoral training at the Johns Hopkins University School of Medicine focused on identifying tumor suppressor genes and oncogenes important to pancreatic tumorigenesis. She joined the faculty of the Johns Hopkins…
Dr. Jian Wang received a medical degree from Shanghai Jiao Tong University School of Medicine and practiced medicine in China. She then obtained a Ph.D. degree in tumor biology and immunotherapy from McGill University in Canada. She has worked in the biotechnology industry studying antisense gene…
Mark D. Lindner, PhD, is currently serving as Acting Branch Chief of the Analysis, Informatics, and Automation (AIA) Branch within the Division of Planning, Analysis, and Information Management (DPAIM) at CSR—a role he assumed in August 2023 following seven years as leader of the Office of Planning…
Reviewers have a broad range of scientific expertise and background. They are experts in the field, but perhaps not in the exact area of your application.
Once you've identified possible study sections/scientific review groups that fit your application well, look at the rosters for the review…
Dr. Katherine Malinda serves as Chief of the Integrative Vascular Biology and Hematology Review Branch (IVBH RB).
Dr. Katherine Malinda received her Ph.D. from Carnegie Mellon University in biological sciences, and was then awarded an intramural research training award to work at the National…
Dr. Alena Savonenko obtained her Ph.D. in behavioral neuroscience at the Lomonosov Moscow State University and completed a post-doctoral fellowship at the Nencki Institute of Experimental Biology, Warsaw, Poland. Later, she continued her post-doctoral education at the Johns Hopkins University.…
May I submit many post submission items, or only one?Why is there a 30-day cutoff for notification that a paper has been accepted?Will NIH accept articles that have been accepted for publication?Why aren’t late-breaking research findings allowed as post-submission material?May I submit newly-…
Does the NIH policy on rigor and transparency apply to all types of NIH grants?
Where in grant applications should applicants address the four focus areas of the NIH policy on rigor and transparency?
What is the difference between "rigor of the prior research" and "significance"?
Should…
Training Resources National Institutes of Health (NIH)
Extramural Training Mechanisms
Careers
K Kiosk - Information about NIH Career Development Awards
National Cancer Institute (NCI)
Training opportunities and funding for cancer training and…
While there is no administrative requirement that the science in a new A0 application be substantively different from any previously reviewed submission, it is not allowable to have duplicate or highly overlapping applications under review at the same time as per 2.3.7.4 Submission of Resubmission…
When multiple PD/PIs are proposed, must all PD/PIs and all institutions involved be AREA-eligible?
When multiple PD/PIs are proposed, must all PD/PIs and all institutions involved be AREA-eligible?
Yes, each PD/PI must have an appointment at an AREA-eligible institution. In addition, each PD…
Some Observations from the NIH Director – Dr. Francis S. Collins, M.D., Ph.D., NIH Director
CSR Advisory Council Update – Dr. Noni Byrnes, Ph.D., CSR Director
ENQUIRE – Evaluating Panel Quality in Review – Dr. Valerie Durrant, Ph.D., CSR DABP Director
ENQUIRE – Evaluating Panel Quality in Review…
Dr. Yi Liu earned his Ph.D. in molecular microbiology and immunology and received his postdoctoral training in developmental genetics from the University of Southern California. Prior to joining CSR, he was an associate professor of research and the principal investigator and co-investigator of NIH…
Dr. Ananya Paria came to CSR after serving in the Population Studies and Genetics Branch of the Division of Neuroscience at the National Institute on Aging. There, she worked in Population Studies and Epidemiology Research Programs on Alzheimer’s disease (AD), AD-related dementias (ADRD), and other…
Selection CriteriaScientists must meet general requirements, expertise requirements, and requirements specific to the given study section/scientific review group. Balancing experience and diversity when developing rosters for a scientific review group is one of the most challenging tasks a…
Scientific and health breakthroughs are heralded in the press almost every day. You often can trace them back—directly or indirectly—to one or more NIH peer review groups that found promise in an application. To illustrate the point, we share the following stories:
Geneticist Advances…
Dr. Ghenima Dirami received a Ph.D. in biochemical endocrinology from the University of London in England. Before joining NIH, Dr. Dirami received her postdoctoral training at Georgetown University. Her research in the Lung Biology Laboratory there focused on oxidant-induced lung injury and on the…
I've read the definitions of Significance and Overall Impact but the two still seem rather similar. Can you provide some additional guidance?
When determining the Overall Impact score, should it equal the arithmetic mean of the scores for the scored review criteria?
Is it possible for an…
Michael McQuestion received a B.S. degree from the University of Notre Dame, an M.P.H. from Tulane School of Public Health and Tropical Medicine and a Ph..D in sociology from the University of Wisconsin- Madison. Prior to joining NIH, Dr. McQuestion was an assistant professor at the Johns Hopkins…
Dr. Pablo M. Blazquez Gamez obtained his Ph.D. in vestibular and cerebellar physiology at Washington University (St. Louis) and Seville University (Spain). He received his postdoctoral training in basal ganglia physiology at the Massachusetts Institute of Technology. Subsequently, he joined the…
Dr. Liangbiao Zheng received his Ph. D. in biology from Harvard University. His postdoctoral training at Harvard focused on molecular genetics of mosquitoes. He continued his research in vector biology with special emphases on host-pathogen interactions and innate immunity as a staff scientist in…
Dr. Afia Sultana earned her Ph.D. in molecular genetics from L. V. Prasad Eye Institute in Hyderabad, India. She pursued her postdoctoral training and served as a senior research fellow in the laboratory of Retinal Cell and Molecular Biology at the National Eye Institute at NIH. Her research…
Dr. Jennifer Sanders received her Ph.D. in molecular biology, cell biology, and biochemistry from Brown University and completed a fellowship in gastroenterology at Rhode Island Hospital. Following fellowship, she joined the faculty at the Warren Alpert Medical School of Brown University. Her…
The ECR program aims to:
Help early career scientists become more competitive for R01 funding by giving them first-hand experience with the review process
Enrich the existing pool of reviewers through increased recruitment of groups traditionally underrepresented on panels such as women,…
